DY131(GSK 9089) is a novel selective agonist of ERRβ and ERRγ: displays minimal activity at ERRα, ERα and ERβ at concentrations up to 30 μM.A novel selective agonist at ERRβ and ERRγ.
DY131(GSK 9089) is a novel selective agonist of ERRβ and ERRγ: displays minimal activity at ERRα, ERα and ERβ at concentrations up to 30 μM.A novel selective agonist at ERRβ and ERRγ.
DY131(GSK 9089) is a novel selective agonist of ERRβ and ERRγ: displays minimal activity at ERRα, ERα and ERβ at concentrations up to 30 μM.A novel selective agonist at ERRβ and ERRγ.
DY131(GSK 9089) is a novel selective agonist of ERRβ and ERRγ: displays minimal activity at ERRα, ERα and ERβ at concentrations up to 30 μM.A novel selective agonist at ERRβ and ERRγ.
DY131(GSK 9089) is a novel selective agonist of ERRβ and ERRγ: displays minimal activity at ERRα, ERα and ERβ at concentrations up to 30 μM.A novel selective agonist at ERRβ and ERRγ.
DY131(GSK 9089) is a novel selective agonist of ERRβ and ERRγ: displays minimal activity at ERRα, ERα and ERβ at concentrations up to 30 μM.A novel selective agonist at ERRβ and ERRγ.
DY131(GSK 9089) is a novel selective agonist of ERRβ and ERRγ: displays minimal activity at ERRα, ERα and ERβ at concentrations up to 30 μM.A novel selective agonist at ERRβ and ERRγ.
DY131(GSK 9089) is a novel selective agonist of ERRβ and ERRγ: displays minimal activity at ERRα, ERα and ERβ at concentrations up to 30 μM.A novel selective agonist at ERRβ and ERRγ.